Fatty acid synthase/oxidized low-density lipoprotein as metabolic oncogenes linking obesity to colon cancer via NF-kappa B in Egyptians

Medical Oncology

Volumn 31, Issue 10, 2014, Pages 1-10

  Keshk, Walaa Arafa ^a   Zineldeen, Doaa Hussein ^a   Wasfy, Rania EL sayed ^a   El Khadrawy, Osama Helmy ^a  

^a TANTA UNIVERSITY   (Egypt)

Author keywords

Cancer colon; Nuclear factor B; Obesity; Oxidized low density lipoprotein; Redox status

Indexed keywords

CHOLESTEROL; FATTY ACID SYNTHASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; TUMOR MARKER; LOW DENSITY LIPOPROTEIN;

AGE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CANCER GROWTH; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COLON; COLON CANCER; COLON CARCINOGENESIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; DYSLIPIDEMIA; EGYPTIAN; ENZYME ACTIVITY; FEMALE; GENDER; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLYCEMIC INDEX; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INSULIN RESISTANCE; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MALE; OBESITY; ONCOGENE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; ADULT; AGED; BLOOD; COLON TUMOR; EGYPT; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; COLONIC NEOPLASMS; EGYPT; FATTY ACID SYNTHASES; FEMALE; HUMANS; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; NF-KAPPA B; OBESITY; ONCOGENES; OXIDATIVE STRESS; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84906601374     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0192-4     Document Type: Article

References (49)

1. Jaems PT. Obesity: the worldwide epidemic. Clin Dermatol. 2004;22:276–80.
2. Chiu HM, Lin JT, Shun CT, Liang JT, Lee YC, Huang SP, Wu MS. Association of metabolic syndrome with proximal and synchronous colorectal neoplasm. Clin Gastroenterol Hepatol. 2007;5(2):221–9.
3. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108.
4. Pyo JH, Kim ES, Chun HJ, Keum B, Jeen YT, Lee HS, Kim CD, Ryu HS, Kim YH, Lee JE. Fasting blood sugar and serum triglyceride as the risk factors of colorectal adenoma in Korean population receiving screening colonoscopy. Clin Nutr Res. 2013;2(1):34–41. doi:10.7762/cnr.2013.2.1.34.
5. Fritz V, Fajas L. Metabolism and proliferation share common regulatory pathways in cancer cells. Oncogene. 2010;29(31):4369–77. doi:10.1038/onc.2010.182.
6. Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer. 2007;7(10):763–77.
7. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39(1):44–84.
8. Luqman S, Pezzuto JM. NFkappaB: a promising target for natural products in cancer chemoprevention. Phytother Res. 2010;24(7):949–63. doi:10.1002/ptr.3171.
9. Vaiopoulos AG, Athanasoula KC, Papavassiliou AG. NF-κB in colorectal cancer. J Mol Med. 2013;91(9):1029–37. doi:10.1007/s00109-013-1045-x.
10. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–54.
11. Duseja A, Thumburu KK, Das A, Dhiman RK, Chawla YK, Bhadada S, Bhansali A. Indian J Gastroenterol. 2007;26(4):170–3.
12. Nepokroeff CM, Lakshmanan MR, Porter JW. Fatty-acid synthase from rat liver. Methods enzymol. 1975;35:37–44.
13. Menendez JA, Lupu R. Fatty acid synthase-catalyzed de novo fatty acid biosynthesis: from anabolic-energy-storage pathway in normal tissues to jack-of-all-trades in cancer cells. Arch Immunol Ther Exp (Warsz). 2004;52(6):414–26.
14. Washington MK, Berlin J, Branton P, Burgart LJ, Carter DK, Fitzgibbons PL, Halling K, Frankel W, Jessup J, Kakar S, Minsky B, Nakhleh R, Compton CC; Members of the Cancer Committee, College of American Pathologists. Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum. Archives of pathology & laboratory medicine.2009;133(10):1539-1551.
15. Kojima M, Morisaki T, Sasaki N, Nakano K, Mibu R, Tanaka M, Katano M. Increased nuclear factor-kB activation in human colorectal carcinoma and its correlation with tumor progression. Anticancer Res. 2004;24:675–81.
16. Oh TH, Byeon JS, Myung SJ, Yang SK, Choi KS, Chung JW, Kim B, Lee D, Byun JH, Jang SJ, Kim JH. Visceral obesity as a risk factor for colorectal neoplasm. J Gastroenterol Hepatol. 2008;23(3):411–7.
17. Bolocan A, Ion D, Ciocan DN, Paduraru DN. Prognostic and predictive factors in colon cancer. Chirurgia (Bucur). 2012;107(5):555–63.
18. Gunter MJ, Leitzmann MF. Obesity and colon cancer: epidemiology, mechanisms and candidate genes. J Nutr Biochem. 2006;17(3):145–56.
19. Bowers K, Albanes D, Limburg P, Pietinen P, Taylor PR, Virtamo J, Stolzenberg-Solomon R. A prospective study of anthropometric and clinical measurements associated with insulin resistance syndrome and colon cancer in male smokers. Am J Epidemiol. 2006;164(7):652–64.
20. Dai Z, Xu YC, Niu L. Obesity and colon cancer risk: a metaanalysis of cohort studies. World J Gastroenterol. 2007;13(31):4199–206. doi:10.1016/j.revmed.2009.04.007.
21. Muñoz-Pinedo C, El Mjiyad N, Ricci JE. Cancer metabolism: current perspectives and future directions. Cell Death Dis. 2012;3(1):e248. doi:10.1038/cddis.2011.123.
22. Little JL, Kridel SJ. Fatty acid synthase activity in tumor cells. Subcell Biochem. 2008;49:169–94. doi:10.1007/978-1-4020-8831-5_7.
23. Yang YA, Han WF, Morin PJ, Chrest FJ, Pizer ES. Activation of fatty acid synthesis during neoplastic transformation: role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Exp Cell Res. 2002;279(1):80–90.
24. Ogino S, Nosho K, Meyerhardt JA, Kirkner GJ, Chan AT, Kawasaki T, Giovannucci EL, Loda M, Fuchs CS. Cohort study of fatty acid synthase expression and patient survival in colon cancer. J Clin Oncol. 2008;26(35):5713–20. doi:10.1200/JCO.2008.18.2675.
25. Nguyen PL, Ma J, Chavarro JE, Freedman ML, Lis R, Fedele G, Fiore C, Qiu W, Fiorentino M, Finn S, Penney KL, Eisenstein A, Schumacher FR, Mucci LA, Stampfer MJ, Giovannucci E, Loda M. Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival. J Clin Oncol. 2010;28(25):3958–64. doi:10.1200/JCO.2009.27.0793.
26. Notarnicola M, Pisanti S, Tutino V, Bocale D, Rotelli MT, Gentile A, Memeo V, Bifulco M, Perri E, Caruso MG. Effects of olive oil polyphenols on fatty acid synthase gene expression and activity in human colon cancer cells. Genes Nutr. 2011;6(1):63–9. doi:10.1007/s12263-010-0177-7.
27. Swinnen JV, Heemers H, Deboel L, Foufelle F, Heyns W, Verhoeven G. Stimulation of tumor-associated fatty acid synthase expression by growth factor activation of the sterol regulatory element-binding protein pathway. Oncogene. 2000;19(45):5173–81.
28. Kuhajda FP. Fatty acid synthase and cancer: new application of an old pathway. Cancer Res. 2006;66(12):5977–80.
29. Menendez JA. Lupu R (2006) oncogenic properties of the endogenous fatty acid metabolism: molecular pathology of fatty acid synthase in cancer cells. Curr Opin Clin Nutr Metab Care. 2006;9(4):346–57.
30. Ezquerra EA, Vázquez JC, Barrero AA. Obesity, metabolic syndrome, and diabetes: cardiovascular implications and therapy. Rev Esp Cardiol. 2008;61:752–64. doi:10.1016/S1885-5857(08)60212-1.
31. Borena W, Stocks T, Jonsson H, Strohmaier S, Nagel G, Bjørge T, Manjer J, Hallmans G, Selmer R, Almquist M, Häggström C, Engeland A, Tretli S, Concin H, Strasak A, Stattin P, Ulmer H. Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study. Cancer Causes Control. 2011;22(2):291–9. doi:10.1007/s10552-010-9697-0.
32. Van Duijnhoven FJ, Bueno-De-Mesquita HB, Calligaro M, Jenab M, Pischon T, Jansen EH, Frohlich J, Ayyobi A, Overvad K, Toft-Petersen AP, Tjønneland A, Hansen L, Boutron-Ruault MC, Clavel-Chapelon F, Cottet V, Palli D, Tagliabue G, Panico S, Tumino R, Vineis P, Kaaks R, Teucher B, Boeing H, Drogan D, Trichopoulou A, Lagiou P, Dilis V, Peeters PH, Siersema PD, Rodríguez L, González CA, Molina-Montes E, Dorronsoro M, Tormo MJ, Barricarte A, Palmqvist R, Hallmans G, Khaw KT, Tsilidis KK, Crowe FL, Chajes V, Fedirko V, Rinaldi S, Norat T, Riboli E. Blood lipid and lipoprotein concentrations and colon cancer risk in the European Prospective Investigation into Cancer and Nutrition. Gut. 2011;60(8):1094–102. doi:10.1136/gut.2010.225011.
33. Yu YH, Ginsberg HN. Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant in adipose tissue. Circul Res. 2005;96:1042–52.
34. Negre-Salvayre A, Coatrieux C, Ingueneau C, Salvayre R. Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. Br J Pharmacol. 2008;153(1):6–20.
35. Bruce WR, Giacca A, Medline A. Possible mechanisms relating diet and risk of colon cancer. Cancer Epidemiol Biomarkers Prev. 2000;9:1271–9.
36. Komninou D, Ayonote A, Richie JP, Rigas B. Insulin resistance and its contribution to colon carcinogenesis. Exp Biol Med (Maywood). 2003;228(4):396–405.
37. Higdon JV, Frei B. Obesity and Oxidative Stress: a Direct Link to CVD. Arterioscler Thromb Vasc Biol. 2003;23:365–7.
38. Zhang Y, Du Y, Le W, Wang K, Kieffer N, Zhang J. Redox control of the survival of healthy and diseased cells. Antioxid Redox Signal. 2011;15(11):2867–908. doi:10.1089/ars.2010.3685.
39. Holvoet P, Kritchevsky SB, Tracy RP, Mertens A, Rubin SM, Butler J, Goodpaster B, Harris TB. The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging and body composition cohort. Diabetes. 2004;53:1068–73.
40. Ray G, Batra S, Shukla NK, Deo S, Raina V, Ashok S, Husain SA. Lipid peroxidation, free radical, and antioxidant status in breast cancer. Breast Cancer Res Treat. 2000;59(2):163–70.
41. Delimaris I, Faviou E, Antonakos G, Stathopoulou E, Zachari A, Dionyssiou-Asteriou A. Oxidized LDL, serum oxidizability and serum lipid levels in patients with breast or ovarian cancer. Clin Biochem. 2007;40(15):1129–34.
42. Bhagat SS, Ghone RA, Suryakar AN, Hundekar PS. Lipid peroxidation and antioxidant vitamin status in colon cancer patients. Indian J Physiol Pharmacol. 2011;55(1):72–6.
43. Marnett LJ. Oxyradicals and DNA damage. Carcinogenesis. 2000;21(3):361–70.
44. Lu J, Mitra S, Wang X, Khaidakov M, Mehta JL. Oxidative stress and lectin-like ox-LDL-receptor LOX-1 in atherogenesis and tumorigenesis. Antioxid Redox Signal. 2011;15(8):2301–33. doi:10.1089/ars.2010.3792.
45. Lührs H, Gerke T, Schauber J, Dusel G, Melcher R, Scheppach W. Menzel T (2001) Cytokine activated degradation of inhibitory kappa B protein α is inhibited by the short-chain fatty acid butyrate. Int J Colorectal Dis. 2001;16(4):195–201.
46. Abdullah M, Sudoyo AW, Pranowo BS, Rini D, Sutrisna B, Rani AA. Expression of NF-kappaB and COX-2 in young versus older patients with sporadic colorectal cancer. Acta Medica Indonesiana. 2009;41(2):70–4.
47. Miriyala S, Spasojevic I, Tovmasyan A, Salvemini D, Vujaskovic Z, St Clair D, Batinic-Haberle I. Manganese superoxide dismutase, MnSOD and its mimics. Biochim Biophys Acta. 2012;822(5):794–814. doi:10.1016/j.bbadis.2011.12.002.
48. Wang SH, Wang YZ, Zhang KY, Shen JH, Zhou HQ, Qiu XY. Effect of superoxide dismutase and malondialdehyde metabolic changes on carcinogenesis of gastric carcinoma. World J Gastroenterol. 2005;11(28):4305–10.
49. Strzelczyk JK, Wielkoszyński T, Krakowczyk Ł, Adamek B, Zalewska-Ziob M, Gawron K, Kasperczyk J, Wiczkowski A. The activity of antioxidant enzymes in colorectal adenocarcinoma and corresponding normal mucosa. Acta Biochim Pol. 2012;59(4):549–56.